Literature DB >> 16525498

Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity.

V Mathews, S Desire, B George, K M Lakshmi, J G Rao, A Viswabandya, A Bajel, V M Srivastava, A Srivastava, M Chandy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16525498     DOI： 10.1038/sj.leu.2404165

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1.

Authors:  Wei Qu; Lida Cheng; Anna L Dill; Joseph E Saavedra; Sam Y Hong; Larry K Keefer; Michael P Waalkes
Journal:  Chem Biol Interact       Date:  2011-05-20       Impact factor: 5.192

2.  Protective effect of naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats.

Authors:  Sam Daniel Mershiba; M Velayutham Dassprakash; Sundara Dhakshinamurthy Saraswathy
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

3.  The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis.

Authors:  Wei Qu; Jie Liu; Richard Fuquay; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Lett       Date:  2007-07-20       Impact factor: 8.679

4.  V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.

Authors:  Wei Qu; Jie Liu; Anna L Dill; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Sci       Date:  2008-12-15       Impact factor: 6.716

5.  Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.

Authors:  Vikram Mathews; Ezhilarasi Chendamarai; Biju George; Auro Viswabandya; Alok Srivastava
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

6.  Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.

Authors:  Patricia A Assis; Lorena L De Figueiredo-Pontes; Ana Silvia G Lima; Vitor Leão; Larissa A Cândido; Carolina T Pintão; Aglair B Garcia; Fabiano P Saggioro; Rodrigo A Panepucci; Fernando Chahud; Arnon Nagler; Roberto P Falcão; Eduardo M Rego
Journal:  J Exp Clin Cancer Res       Date:  2015-06-23

7.  Protective Effects of Eugenol against Hepatotoxicity Induced by Arsenic Trioxide: An Antileukemic Drug.

Authors:  Prakash Binu; Nellikunnath Priya; Surendran Abhilash; Radhakrishnan Chandraprabha Vineetha; Harikumaran Nair
Journal:  Iran J Med Sci       Date:  2018-05

8.  Arsenic induced redox imbalance triggers the unfolded protein response in the liver of zebrafish.

Authors:  Patrice Delaney; Anjana Ramdas Nair; Catherine Palmer; Nouf Khan; Kirsten C Sadler
Journal:  Toxicol Appl Pharmacol       Date:  2020-11-02       Impact factor: 4.219

9.  Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As2O3.

Authors:  Wen-Sheng Liu; Xin-Yu Wang; Jing Lu; Ying-Mei Zhang; Xiang-Mei Ye; Jin-Mei Li; Qi-Lei Zhao; Zhi-Qiang Wu; Jin Zhou; Xin Hai
Journal:  Arch Toxicol       Date:  2020-02-28       Impact factor: 5.153
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.